Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



The 10 Most Common Reasons People Visit Their Doctor

With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the country should be bracing for what could be an influx of new patients. With the mandate for insurance comes the potential that more people (both those covered under Medicaid expansion and self-insured individuals) may choose to visit their doctor more often to address ongoing and preventative concerns.

Source: Vic, Flickr.

From an investing standpoint and as a society, we understand what diseases are most prevalent, where the trends are rising, and what medications are being developed to treat these diseases. Obesity, for instance, is a disease that affects 35.7% of the U.S. population, and with it comes a considerably higher risk of developing high blood pressure, high cholesterol, diabetes, and cancer. Similarly, some 25 million people in the U.S. are diabetic, with another nearly 80 million in a pre-diabetes stage. You'd think with staggering figures like these that the majority of doctors office visits would be related in some way to chronic weight or diabetic issues.

But that's just not the case, according to a large study conducted by the Mayo Clinic, which looked at 142,377 patients between 2005 and 2009 to determine why exactly they went to see their doctor. Your initial impression might be to assume that high-profile and prevalent diseases tend to be the main reason people go see their doctor, but it actually tends to be more subtle symptoms that drive us to seek help. 

Here are the 10 most common reasons the Mayo Clinic listed in its study for why people go see their doctor :

1. Skin disorders, including cysts, acne, and dermatitis.
2. Joint disorders, including osteoarthritis.
3. Back problems.
4. Cholesterol problems.
5. Upper respiratory conditions (excluding asthma).
6. Anxiety, bipolar disorder, and depression.
7. Chronic neurologic disorders.
8. High blood pressures.
9. Headaches and migraines.
10. Diabetes.

Skin disorders
According to the Mayo Clinics' study, nearly 43% of respondents went to see their doctor in at least some context because of a dermatologic disorder. What this means for you as an investor is that there could be a huge growth potential in skin-disorder companies should more people choose to visit their physicians next year.

There are quite a few ways of profiting off skin disorders, since it's such a broad encompassing disorder that can range from aesthetic issues like acne to serious complications like melanoma. Beyond your commonly found over-the-counter medications, one interesting example of a potential beneficiary is Trius Therapeutics (UNKNOWN: TSRX.DL  ) , the developer of experimental acute bacterial skin and skin structure infection drug, tedizolid. In trials, the drug, which is designed to treat methicillin-resistant staphylococcus aureus, better known as MRSA, reduced lesion sizes by at least 20% in 85.2% of patients in a 48-hour to 72-hour time period, which was slightly higher than Pfizer's (NYSE: PFE  ) Zyvox, which is the current standard of treatment. However, tedizolid achieved its results in just a six-day dosing period compared with Zyvox's 10-day standard treatment. With Cubist Pharmaceuticals agreeing to purchase Trius less than two weeks ago, it could be snagging itself quite the bargain.

On a larger scale, GlaxoSmithKline (NYSE: GSK  ) is also a big skin-disorder player, but primarily from the point of cancer treatment. Earlier this year, Glaxo received Food and Drug Administration approval for both Taflinar and Mekinist for the treatment of advanced melanoma. Both drugs are single agents (meaning either one or the other will be prescribed), with each targeting a BRAF mutation commonly found among melanoma patients. Not to mention that Glaxo also received FDA approval for its diagnostic test to determine whether patients possess this mutation. With few melanoma advances in recent years, Glaxo has a solid chance to build a name for itself in this market.

Joint disorders
Bone and joint health are common disorders that should have popped into my head earlier as a possible reason for a doctor's visit, but they are also often overlooked by investors despite accounting for 33.6% of all doctor's visits based on this study. Rather than looking to pre-existing treatments I would like to turn your attention to an up-and-coming experimental drug that has a strong chance to be a blockbuster from Merck (NYSE: MRK  ) known as odanacatib.

If there were any doubts about the effectiveness of odanacatib, a drug designed to reduce fracturing in bones, they flew the coop in late-stage trials when an outside monitoring committee stopped the trial early because of its overwhelming success. Although Merck is taking its time with its potential blockbuster and waiting until 2014 to file for a new drug application, it has the potential to garner $3 billion or more in peak sales if approved.

Back problems
Talk about another category that can have a bevy of problems ranging from something as minor as a muscle pull to some serious like pain caused by cancer. Back problems were named in nearly one-quarter (23.9%) of all doctors' visits and have the potential to be a big moneymaker for big pharmaceuticals and investors.

Source: Au Kirk, Flickr.

One clear way to play this is by sticking with an iconic over-the-counter medication known to relieve pain, Tylenol, which is still manufactured by Johnson & Johnson. Clearly J&J's revenue stream is incredibly diverse, with consumer products, medical devices, and pharmaceuticals combining to equal a really large pie, but you would be surprised how often physicians suggest to patients a regimen that involves over-the-counter anti-inflammation products like Tylenol to alleviate non-serious back pain.

Cholesterol problems
High cholesterol at the No. 4 spot (named in 22.4% of all doctor's visits by respondents) might be the first truly expected ailment that appeared on this list. As I mentioned earlier, with more than a third of this nation's adults being obese, this group of people runs a considerably higher risk of developing obesity-related complications, which can range from high blood pressure and high cholesterol, to more immediately serious diseases like cancer. Cholesterol-lowering drugs have the potential to make a meaningful and long-lasting impact on improving the quality of life for a good chunk of Americans, which is why pharmaceutical companies are investing so heavily in new medications now.

A new medication I've hailed as a game-changer on numerous occasions since its approval in May is Liptruzet. This combination drug, which is made up of a statin -- Pfizer's now generic Lipitor -- and Merck's cholesterol absorption inhibitor Zetia, delivered a far bigger effect on reducing LDL-cholesterol (the bad kind) than either Lipitor or Zetia could on their own in trials. Liptruzet's LDL-reduction totaled 53% to 61% as compared with Lipitor and Zetia, which demonstrated LDL-reductions of 37% to 54% and 20%, respectively. As long-term safety concerns for these revolutionary new LDL-reducing drugs lessen, the number of prescriptions written for them by physicians is likely to improve.

Upper respiratory conditions
The fifth most common reason for visiting the doctor, upper respiratory conditions, was my blind guess as the most common reason people went to the doctor before reading the Mayo Clinic's study. This broad topic, which encompassed 22.1% of respondents, can range from something as simple as a bacterial or viral infection that had settled in a patient's chest to something much more severe like cancer.

Source: Steven Depolo, Flickr.

With the good likelihood that a vast majority of upper respiratory-related doctor visits have to do with some form of bacterial or viral infection, my suggestion here would be to look into flu vaccine manufacturers. Sanofi (NYSE: SNY  ) , for example, developed roughly 60 million doses of its Fluzone for this past year's flu season and, by January, had sold out of many variations of the vaccine. It's a bit difficult to tell how in-demand the flu vaccine will be from one season to the next, but I believe Sanofi's sales this past year speak for themselves.  

What's your reason?
Sometimes getting in ahead of the next big sales trends in the pharmaceutical industry involves looking at studies like this one and understanding why people go to their doctor in the first place. With a better understanding of why other people go see their doctor, perhaps being honest with yourself and asking yourself the same question might clue you into the next great health-care investment opportunity!

Going to your doctor is important, but so is taking care of your investments. In other words, your financial health is just as important as your personal health. The Motley Fool's special free report "3 Stocks That Will Help You Retire Rich" names specific investment opportunities that could help you build long-term wealth and help you retire well. The Fool also outlines critical wealth-building strategies that every investor should know. Click here to keep reading.

Read/Post Comments (14) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 11, 2013, at 3:40 PM, limie50 wrote:

    Really ... is this article really educational or biased toward the Drug industry.

    pathetic how DRUGS are marketed as 'solutions' when in fact they are a big part of our sick population. Way to go Motley in misleading people ... once again.

    more pathetic is that our #1 business of the future will be sucking money of out people for healthcare. Manufacturing will be a distant second.

    We will remain an unhealthy nation with unhealthy commerce.

  • Report this Comment On August 11, 2013, at 3:59 PM, spintreebob wrote:

    The question is WHY. And Mayo is in the wrong paradigm. For example, included in the top ten MUST be pressure from family, friends, co-workers, employers. That is WHY. The symptoms are the WHAT, but seldom the WHY.

  • Report this Comment On August 11, 2013, at 4:06 PM, gmvalentine wrote:

    Tylenol (acetaminophen) is not anti-inflammatory.Over the counter anti-inflammatory drugs (NSAIDs) are ibuprofen (Advil, Motrin), naproxen (Aleve), and aspirin.

  • Report this Comment On August 11, 2013, at 4:28 PM, luckyagain wrote:

    This makes sense. The skin is the largest organ of the human body and is the most exposed by far. The skin is the protector of everything else except for the eyes. Also it is the one with the largest number of nerve/pain receptors. So when it is in pain, it gets your attention. Things like high blood pressure and cardiovascular disease usually does not cause pain until a lot of internal damage has been done. So while high blood pressure or cardiovascular disease is much more fatal, it is also much less painful until it becomes critical.

  • Report this Comment On August 11, 2013, at 4:34 PM, Tonenine wrote:

    As a former man of medicine, I can tell you with certainty you missed one of the biggest reasons a person goes to the physician and that reason is loneliness!!!

  • Report this Comment On August 11, 2013, at 4:35 PM, mr091468 wrote:

    Screw the government's interference in our personal relationships with our doctors. BS has to be stopped. The DC prostitutes don't have to adhere to obammmmma non care. Why should we have to? Doctors are leaving the profession altogether or they've given up on medicare because with their education and backgrounds why should they work for prostitutes?

  • Report this Comment On August 11, 2013, at 5:48 PM, VitamanD wrote:

    Huge disconnect between the first paragraph and the examples given.... MRSA is not something that your average person comes in off the street with, nor is advanced melanoma. had to stop reading after that.

  • Report this Comment On August 11, 2013, at 6:02 PM, tom474e wrote:

    Tylenol, acetaminophen, only has mild anti inflammatory properties. Aspirin and ibuprofen are much more potent anti inflammatory drugs. Tylenol causes liver damage even at the recommended dose, many countries have banned the use of Tylenol, acetaminophen.

  • Report this Comment On August 11, 2013, at 7:07 PM, sickofbs123 wrote:

    What the hell does an osteoporosis drug have to do with joint pain?!? And Tylenol for back pain? I live with chronic joint and back pain with no relief from all the worthless drugs the Dr. has prescribed. I've never smoked pot but would like to try it as a pain alternative, but since I live in a backwards state that doesn't allow it, yet the pharmaceutical industries can profit off of the huge price they put on their toxic drugs that do crap! is the right name for this site, only a fool would believe the for profit lies that are in this stupid article!

  • Report this Comment On August 11, 2013, at 9:55 PM, bamissfa wrote:

    most likely the majority of people visit their doctor ONLY because they are required to in order to get their prescriptions refilled.

  • Report this Comment On August 11, 2013, at 10:53 PM, rbwcsw wrote:

    And this is exactly what's wrong with healthcare in America. Showing people how to profit on someone else's misery. Disgusting!

  • Report this Comment On August 11, 2013, at 10:57 PM, hifive55 wrote:

    The information in this article is such bunk!

    With the Motley slogan of "to educate, amuse and enrich" this must fall into the amuse section. It's laughably fact-free.

  • Report this Comment On August 12, 2013, at 12:58 AM, Vovibook wrote:

    I go to see my chiropractor and it helps!!!

  • Report this Comment On August 13, 2013, at 10:05 AM, wendybTn wrote:

    Motley Fool You are truly a fool if you believe a new insurance card is going to instantly produce more doctors willing to take the much lower payments. Nor will it open up more appointments in an office. Plus, if the practice cannot support itself, the MD will look to join a hospital corporation to support himself. Then there will be even fewer docs with open appointments. Get it yet, America?

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2589916, ~/Articles/ArticleHandler.aspx, 9/26/2016 8:39:10 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:02 PM
GSK $43.42 Down -0.16 -0.37%
GlaxoSmithKline CAPS Rating: ***
MRK $62.96 Down -0.06 -0.10%
Merck and Co. CAPS Rating: ****
PFE $34.26 Up +0.11 +0.32%
Pfizer CAPS Rating: ****
SNY $38.35 Down -0.22 -0.57%
Sanofi CAPS Rating: *****
TSRX.DL $0.00 Down +0.00 +0.00%
Trius Therapeutics CAPS Rating: ***